Estimating healthcare resource use associated with the treatment of metastatic melanoma in eight countries

Journal of Medical Economics
Jan McKendrickZhongyun Zhao

Abstract

Objectives Studies reporting healthcare resourse use (HRU) for melanoma, one of the most costly cancers to treat, are limited. Using consistent, robust methodology, this study estimated HRU associated with the treatment of metastatic melanoma in eight countries. Methods Using published literature and clinician input, treatment phases were identified: active systemic treatment (pre-progression); disease progression; best supportive care (BSC)/palliative care; and terminal care. HRU elements were identified for each phase and estimates of the magnitude and frequency of use in clinical practice were obtained through country-specific Delphi panels, comprising healthcare professionals with experience in oncology (n = 8). Results Medical oncologists are the key care providers for patients with metastatic melanoma, although in Germany dermato-oncologists also lead care. During the active systemic treatment phase, each patient was estimated to require 0.83-2 consultations with a medical oncologist/month across countries; the median number of such assessments in 3 months was highest in Canada (range = 3.5-5) and lowest in France, the Netherlands and Spain (1). Resource use during the disease progression phase was intensive and similar a...Continue Reading

References

Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neal J Meropol, Kevin A Schulman
Mar 25, 2009·Nature Reviews. Cancer·Don X NguyenJoan Massagué
Jun 30, 2009·Applied Health Economics and Health Policy·Keith L DavisJedd D Wolchok
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Aug 24, 2010·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·J R MarsdenUNKNOWN British Association of Dermatologists (BAD) Clinical Standards Unit
Jul 22, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Dolores IslaHenrik W Finnern
Nov 2, 2011·Journal of the American Academy of Dermatology·Donatus U EkwuemeSuephy C Chen
Apr 7, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K JohnstonM van Baardewijk
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria ColombinoGiuseppe Palmieri
Jun 30, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C LebbeM Maio
Sep 18, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Claus GarbeUNKNOWN European Organization of Research and Treatment of Cancer
Nov 3, 2012·Journal of Experimental & Clinical Cancer Research : CR·Michele MaioCarlo Lucioni
Dec 29, 2012·International Journal of Preventive Medicine·Mohammad Reza MaracyMaryam Tirani
Apr 16, 2013·Journal of the National Comprehensive Cancer Network : JNCCN·Daniel G CoitUNKNOWN National Comprehensive Cancer Network (NCCN)
May 15, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kun KimNahila Justo
Jul 3, 2013·Current Medical Research and Opinion·Christophe BedaneUNKNOWN French investigators of the MELODY study
Jul 30, 2014·International Journal of Cancer. Journal International Du Cancer·Paul HanlyLinda Sharp
Feb 25, 2015·Current Medical Research and Opinion·Xue SongMarilyn Novich
Apr 23, 2015·Journal of Cellular Physiology·Alexander MarzukaMarcus Bosenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Shkun ChaddaNils-Olof Bengttson
The Journal of Family Practice
T J Zuber
© 2021 Meta ULC. All rights reserved